- Innovation
Unleashing the Potential of AI
How Bayer uses Artificial Intelligence to drive Breakthrough Innovation.
Bayer is transforming health and nutrition by harnessing cutting-edge artificial intelligence (AI) technologies to catalyze faster product development and improve the way we manufacture and deliver products to our customers. With our mission “Health for all, hunger for none” always in mind, we are guiding our use of AI through a principled, purpose-led approach. To bring meaningful innovations to patients, farmers and consumers fast, we leverage AI as strategic tool to deliver unprecedented value.
"With its ability to improve the lives of millions, AI is a game-changer. It is a collaborative effort – made possible by the talent and dedication of teams across Bayer’s divisions and IT, as well as partnerships with leading technology companies and institutions. We have only begun to tap the transformative power of AI, and the best is yet to come."
''By harnessing AI, we empower consumers to make more informed health decisions through science-based insights and trusted self-care solutions. By combining human expertise with advanced technology, we aim to help billions of people live healthier lives, faster & better."
"The right data is critical to AI. Precise and effective insights and predictions can only be achieved with high-quality data that is accurate and complete. Bayer developed a group-wide data strategy that focuses on aspects such quality, integration, analytics, and security to ensure that our data assets are reliable, valuable, and secure."
"Data sciences and artificial intelligence are transforming the way we discover new medicines. These technologies are catalysts in our pursuit to find scientific solutions faster, more efficiently, and more creatively to support the patients we serve. The emerging impact of AI shows that we are entering a new era of life science innovation."
"We are advancing our digital capabilities in data, AI, and software engineering, ensuring we remain at the forefront of next-gen innovations. This enables us to develop superior products and solutions for our customers with remarkable speed, making informed decisions based on extensive data. Leveraging these tools, we are bringing advancements to market that enable new productive crop production."
AI for Farmers: Data-driven Decisions
Our use of AI supports farmers in making data-driven decisions, including decisions about planting, irrigation, pest management and crop protection. With these technologies, Bayer is advising farmers on crucial decisions such as optimal planting and irrigation times. By supporting earlier identification of disease and pest risks, AI can help farmers make more informed crop-management decisions. Additionally, Crop Science researchers leverage AI and data science to analyze genomic data, accelerating the breeding cycle from 5-6 years to ~4 months and cutting overall product development time by up to 2 years. It supports improvements in product performance, with an aim to increase the rate of genetic gain by 2030. Crop resilience is an important factor in supporting yield and quality under challenging growing conditions.
AI for Patients: Much-needed Treatments
AI is helping to bring much-needed treatments to patients with increasing speed and efficiency – making it a powerful tool in the fight against disease. Hundreds of initiatives are underway to leverage AI in our quest to transform healthcare. Our data scientists are developing cutting-edge technologies to help us make better, more informed decisions faster in many areas of our business. In the immensely complex and time-consuming process of discovering new medicines, AI is revolutionizing the way potential compounds are being identified. To improve the clinical trial process, we’re using AI to plan and analyze clinical trials safely and efficiently. AI is also playing a critical role in medical coding, automating the tedious process of translating of physician-collected data into standardized terms. Our proprietary AI solution, validated by human review, has saved approximately 19 years of manual work since 2017. Bayer is also using AI to drive innovation in radiology. In 2022, we have launched Calantic Digital Solutions, a platform designed to support radiologists by automating time-consuming tasks, accelerating workflows, and enabling improved detection.
AI for Consumers: Reach more people with trusted self-care solutions, faster
We have built an AI platform that enables a consistent, scalable, and repeatable brand-growth model, defining excellence in building Bayer’s trusted self-care brands and better addressing consumer needs. We empower people to take control of their health by delivering more relevant self-care content powered by AI and offering personalized solutions through digital health applications such as Cara Care for irritable bowel syndrome, the intimate health symptom checker on the Canesten website, and the Bayer Aspirin heart health risk assessment tool. At the same time, AI agents are transforming our manufacturing processes, and AI-driven demand forecasting ensures high-quality products are available when and where they are needed, whether in pharmacies, stores, or online, helping consumers with trusted solutions to relieve their health symptoms
AI in our Operations: Efficiency across all Operations
Using AI as a strategic tool, Bayer is amplifying our capacity for innovation and providing more personalized, accessible solutions to our customers with exceptional efficiency. AI helps identify potential safety issues, as well as aids in monitoring and complying with regulations. AI is used in selected supply-chain and distribution processes to support planning, identify potential inefficiencies and improve operational decision-making enabling us to serve our customers better and faster through more efficient distribution of products.
Ethical and Responsible Use of AI
Bayer is committed to developing and using AI in a human-centered, responsible, and trustworthy way. We seek to harness AI’s potential to advance scientific discovery, and support work related to health outcomes and food security. Our approach to AI is guided by clear principles that help ensure the technology serves people, supports sound judgment, and is used responsibly across its lifecycle. We design and use AI with meaningful human oversight, especially in contexts that may affect health, safety, livelihoods, the environment, or critical business decisions. We remain accountable for AI-enabled outcomes, apply risk-based governance and safeguards, and work to ensure AI systems are transparent, reliable, and fit for purpose. That includes a strong focus on data quality, fairness, privacy, security, and the mitigation of bias. Our approach is informed by internationally recognized frameworks and strengthened by internal governance structures as well as the independent external expertise of Bayer’s Bioethics Council, helping us advance AI innovation with both scientific rigor and ethical responsibility.
Generative AI at Bayer: Transformative Potential
Throughout our history, Bayer has embraced technological breakthroughs that augment our tool books. We thrive on the use of disruptive innovations, recognizing the intrinsic value and competitive edge they provide. Bayer has strategically invested in the internal development of myGenAssist – a secure, bespoke gen AI platform tailored to Bayer’s unique needs. It provides more than 40,000 employees with virtual assistants that are connected to internal and external data sources, enabling employees to access expertise and create content more quickly. In addition, we have established APIs for in-house applications to adapt the best AI models to hundreds of specific business cases and are already reaping early benefits. As AI matures so will myGenAssist as a key tool to harness the technology’s potential at scale.
AI Powered by People
Across Bayer, hundreds of initiatives are underway to leverage AI in our quest for innovation. The impact that artificial intelligence is already having today makes it clear that we are only at the beginning of an era of unimaginable innovation. Driven by our scientific values and our vision of effective, and accessible Health for All, Bayer scientists will continue to explore how this paradigm-shifting technology can be used for better.
AI & Partnerships: Strength through Collaboration
Bayer is committed to fostering valuable relationships with strategic partners. We seek partnerships that enhance our industry leadership and, more importantly, provide immense value to our customers. Discover some of our current alliances that augment internal expertise and elevate the possibilities of healthcare and agricultural breakthroughs.
AI Outlook: The best of AI remains to unfold
Across Bayer, hundreds of initiatives are underway to leverage AI in our quest for innovation. The impact that artificial intelligence is already having today makes it clear that we are only at the beginning of an era of unimaginable innovation. Driven by our scientific values and our vision of effective, and accessible Health for All, Bayer scientists will continue to explore how this paradigm-shifting technology can be used for better.